ABSI News and Press, Absci Corporation From 11/02/22

VANCOUVER, Wash. and NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), leaders in the protein drug creation revolution harnessing generative AI and scalable biological data to design better therapeutics, faster, today announced the company will be participating i...

VANCOUVER, Wash. and NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced Meta Connectivity VP Dan Rabinovitsj as the newest member of its Board of Directors. With three decades of leadership in scaling tech...

VANCOUVER, Wash. and NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), leaders in the protein drug creation revolution harnessing generative AI and scalable biological data to design better therapeutics, faster, today announced the company will be participating i...

- Dr. Busch transitions from Absci’s Board of Directors to Absci’s Executive Leadership team -With a proven track record advancing drugs from discovery to market, Dr. Busch brings world-class R&D expertise to Absci’s executive leadership team VANCOUVER, Wash. ...

VANCOUVER, Wash. and NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating in t...

Despite over 14% rise in its share price on Thursday, JPMorgan has downgraded Absci Corporation ( NASDAQ: ABSI ), which runs a drug creation platform, to Underweight from Overweight, noting issues with its product mix. Citing Absci's ( ABSI ) Q2 2022 financials, the analyst ...

Neptune Wellness Solutions ( NEPT ) +48% . ADDvantage Technologies Group ( AEY ) +33% Technologies GAAP EPS of $0.07, revenue of $27.79M. Larimar Therapeutics ( LRMR ) +31% on plans to resolve clinical hold on lead asset. Twin Vee Powercats ...

Absci Corp ( NASDAQ: ABSI ) shares r ose as much as 37% in Thursday trading despite reporting Q2 financial results that missed on the top and bottom lines . In afternoon trading, shares are up 16% . However, the company noted that a strategic reorganiz...

Absci press release ( NASDAQ: ABSI ): Q2 GAAP EPS of -$0.32 misses by $0.01 . Revenue of $1M (+42.9% Y/Y) misses by $0.68M . Cash and cash equivalents as of June 30, 2022 was $206.0 million, as compared to $252.6 million as of December 31, 2021. The c...

Exceeded annual Active Program guidance with ten programs signed year-to-date Executed strategic reorganization to extend cash runway into late-2025 VANCOUVER, Wash. and NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target disco...